Clinical trial
Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy…
NCT00187681 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00187681 |
|---|---|
| Title | Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects |
| Official title | Effect of Genetic Variants in the Xenobiotic Transporter, OCT1, on Response to Metformin in Healthy Subjects |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Other Conditions That May Be A Focus of Clinical Attention |
| Intervention type | Drug |
| Interventions | Metformin |
| Enrollment | 20 |
| Start date | Jul 1, 2003 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: